TransTech, Forest sign diabetes drug license deal - BusinessWeek

[INCIID News Feed]

RTT News
<img alt="" height="1" width="1" />
TransTech, Forest sign diabetes drug license deal
BusinessWeek
TransTech Pharma Inc. and Forest Laboratories Inc. said Tuesday they entered a license agreement potentially worth more than $1.1 billion for the development of diabetes drugs. Under the deal, Forest will pay privately held TransTech $50 million ...
TransTech Signs $1B Diabetes Drug Deal with Forest LabsBioWorld Online
Forest Labs, TransTech In Licensing Deal For Up To $1.11 BlnWall Street Journal
Forest Laboratories Pays TransTech Pharma $50M Up Front in Diabetes DealGenetic Engineering News
FierceBiotech -MarketWatch (press release) -Interactive Investor
all 46 news articles &raquo;


More...